Nowbakht, P., Ionescu, M.C., Rohner, A., Kalberer, C.B., Rossy, E., et al. (2005) Ligands for Natural Killer Cell-Activating Receptors Are Expressed upon the Maturation of Normal Myelomonocytic Cells But at Low Levels in Acute Myeloid Leukemias. Blood, 105, 3615-3622.
https://doi.org/10.1182/blood-2004-07-2585

has been cited by the following article:

• TITLE: Soluble MICB in Plasma and Urine Explains Population Expansions of NKG2D+CD4 T Cells Inpatients with Juvenile-Onset Systemic Lupus Erythematosus

  AUTHORS: Satoru Hamada, Andrea Caballero-Benitez, Kate L. Duran, Anne M. Stevens, Thomas Spies, Veronika Groh

  KEYWORDS: NKG2D Ligands, NKG2D+ CD4 T Cells, Juvenile-Onset Systemic Lupus Erythematosus, B Cells, Monocytes

  JOURNAL NAME: Open Journal of Immunology, Vol.7 No.1, March 29, 2017

  ABSTRACT: Abnormal NKG2D ligand expression has been implicated in the initiation and maintenance of various auto-inflammatory disorders including systemic lupus erythematosus (SLE). This study’s goal was to identify the cellular contexts providing NKG2D ligands for stimulation of the immunosuppressive NKG2D+CD4 T cell subset that has been implicated in modulating juvenile-onset SLE disease activity. Although previous observations with NKG2D+CD4 T cells in healthy individuals pointed towards peripheral B cell and myeloid cell compartments as possible sites of enhanced NKG2DL presence, we found no evidence for a disease-associated increase of NKG2DL-positivity among juvenile-onset SLE B cells and monocytes. However, juvenile-onset SLE patient plasma and matched urine samples were positive by ELISA for the soluble form of the NKG2D ligands MICA and MICB, suggesting that kidney and/or peripheral blood may constitute the NKG2DL positive microenvironments driving NKG2D+CD4 T cell population expansions in this disease.